Compare MCRB & MMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCRB | MMTX |
|---|---|---|
| Founded | 2010 | 2025 |
| Country | United States | Taiwan |
| Employees | N/A | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.0M | 88.9M |
| IPO Year | 2015 | N/A |
| Metric | MCRB | MMTX |
|---|---|---|
| Price | $7.65 | $10.07 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 38.5K | 19.5K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $789,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $139.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.56 | $9.89 |
| 52 Week High | $29.98 | $10.09 |
| Indicator | MCRB | MMTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 71.16 |
| Support Level | $7.33 | $9.90 |
| Resistance Level | $8.29 | $10.09 |
| Average True Range (ATR) | 0.43 | 0.01 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 48.69 | 60.00 |
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Miluna Acquisition Corp is a blank check company.